With Trump's tax cuts extended and Medicaid restrictions tightened, the bill is poised to redraw the contours of America’s healthcare lands...

Vyome Therapeutics, a biotech company backed by Manipal group chief Ranjan Pai, will go public in the US through a reverse merger with US-b...

Mubadala Investment Company to acquire a minority stake in Manipal Health Enterprises. Temasek, a Singapore-government fund and the majorit...

Influenced by diet, lifestyle, and community, Blue Zones offer valuable insights into promoting longevity and well-being. Singapore recentl...

When China abruptly dismantled its "zero COVID" regime last month to let the virus spread freely, the balance tilted to a definite "No", th...

The failure of most forecasters to see the persistent inflation coming out of the pandemic has led to much soul-searching and questioning o...

In India, the Surrogacy (Regulation) Act, which came into effect on January 25, has made it very difficult for couples to have children thr...

The stress of carrying card debt through adulthood is linked to poor health, including joint pain or stiffness that interferes with daily a...

In about two weeks millions of Americans could lose a crucial economic lifeline of this pandemic: $600 a week in extra federal unemployment...

‘The global investor would find merits in a company like Reliance’

The International Monetary Fund fails to agree to pump more liquidity into world economy.

Less than 25 km from Maruti's violence-hit plant in Manesar, tempers have flared up among 2,000 employees of Gurgaon-based Eastern Medikit ...

Our expert guides you in matters relating to insurance.

Marcus Wells and Shirley Walker view their economic prospects from opposite ends of the age spectrum.

Michael Milken, the former junk bond chief from Drexel Burnham Lambert, who served prison time for securities fraud, is back raising money.

The world’s biggest bondholders are determined to make an example of Henry Kravis. Pacific Investment Management and Advantus Capital Manag...

US- based VCs have lined up about $ 4.4 bn for early -stage investment in India over next 4-5 yrs.